Class 2 recall- Compound Sodium Lactate Solution for Infusion BP (Hartmann's Solution for infusion) in Viaflo 1000ml

Baxter Healthcare is recalling one batch of Compound Sodium Lactate (Hartmann’s Solution) 1000mL. This is due to a packaging error where some cartons labelled as Hartmann’s Solution may contain Ringer’s Solution 1000mL.

MHRA drug alert linkhttps://www.gov.uk/drug-device-alerts/class-2-medicines-recall-baxter-healthcare-limited-compound-sodium-lactate-solution-for-infusion-bp-hartmanns-solution-for-infusion-in-viaflo-1000ml-el-25-a-slash-46?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=4134130c-5221-48d2-8fe8-bc296bb64f23&utm_content=immediately

MHRA drug alert date 28/10/25

Further Information

For all medical information enquiries and information on this product, please email Medinfo_UKI@baxter.com, or telephone 0800 0260514. 

For stock control enquiries please email victoria_franklin@baxter.com, or telephone +44 07825 374866. 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 3 recall Ipratropium Bromide 500 microgram / 2ml Nebuliser Solution

Accord Healthcare Ltd is recalling a batch of Ipratropium Bromide 500 microgram/2ml Nebuliser Solution after a foil pouch was found to contain ampoules with incorrect labels intended for the Korean market

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-accord-healthcare-ltd-ipratropium-bromide-500-microgram-slash-2ml-nebuliser-solution-el-25-a-slash-45?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=3205dad9-9795-48a8-bfca-a50aae5041c2&utm_content=immediately

MHRA drug alert date 23/10/25

Further Information

For all medical information enquiries and information on this product, please email Accord-UK Medical Information Department medinfo@accord-healthcare.com, or telephone 01271 385257.

For stock control enquiries please email Accord-UK Customer Services Team customerservices@accord-healthcare.com, or telephone 0800 373573.

Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 caution in use- Relonchem Ltd, Various Products

Relonchem Ltd has informed the MHRA that duplicate GTIN numbers have been assigned to certain Losartan potassium/Hydrochlorothiazide coated tablets in error and a duplicate EAN number has been assigned to certain Risperidone tablets in error.

MHRA drug alert date 23/10/25

MHRA drug alert link: Class 4 Medicines Defect Notification: Relonchem Ltd, Various Products, EL(25)A/44 - GOV.UK

This is a caution in use only we are not accepting stock returns

Further Information

For all medical information enquiries and information on this product, please email medicalinformation@relonchem.com, or telephone 0151 556 1860.

For stock control enquiries please email medicalinformation@relonchem.com, or telephone 0151 556 1860.

Class 4 caution in use- Gemcitabine 2g/52.6ml concentrate for solution for infusion

Hikma Farmacêutica (Portugal) S.A has informed the MHRA that the Patient Information Leaflet (PIL) contained within batch CB0033 of Gemcitabine 2g/52.6ml concentrate for solution for infusion does not contain the side effects of serious skin reactions.

MHRA drug alert Date: 04/09/25

MHRA drug alert link: Class 4 Medicines Defect Notification: Hikma Farmacêutica, Gemcitabine 2g/52.6ml concentrate for solution for infusion, EL(25)A/43 - GOV.UK

This is a caution in use only we are not accepting stock returns

further information

For medical information queries please telephone +351 21 960 8410, or email portugaleupharmacovigilance@hikma.com.

For all stock control enquiries please telephone +44 020 7399 2760, or email customerserviceuk@hikma.com

Field Safety notice- Medihoney products

Packaging failures were identified related to the MediHoney® Wound and Burn products

Date of recall 02/09/25

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 caution in use-Ipca Laboratories UK Limited, Various Products

Ipca Laboratories UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the products listed in this notification do not contain all the required safety information.

MHRA drug alert date 27/08/25

MHRA drug alert link:Class 4 Medicines Defect Notification: Ipca Laboratories UK Limited, Various Products, EL(25)A/42 - GOV.UK

This is a caution in use only we are not accepting stock returns

Further Information

For all medical information enquiries and information on this product, please contact via email address:pharmacovigilance@ipcauk.com or via telephone: 08003685328

For stock control enquiries please contact via telephone: +44 (0)7446 189 936.

Class 4 caution in use - Fexofenadine Hydrochloride 120mg film-coated tablets Active

Class 4 caution in use - Fexofenadine Hydrochloride 120mg film-coated tablets

Chanelle Medical Unlimited Company has informed the MHRA of an error with the European Article Number (EAN) / Global Trade Item Number (GTIN) barcode on the cartons of the above batch of Fexofenadine Hydrochloride 120mg film-coated tablets, distributed by Healthcare Pharma Limited. When scanned, the EAN/GTIN barcode identifies the product as Naratriptan 2.5mg Tablets..
 
MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-notification-fexofenadine-hydrochloride-120mg-film-coated-tablets-chanelle-medical-unlimited-company-el-25-a-slash-41?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=6190b8e4-635d-43ca-b371-997872fb962f&utm_content=immediately

MHRA drug alert date: 21/08/25

This is a caution in use only we are not accepting stock returns
 
For all medical information enquiries and information on this product, please contact Medical Information Department chanelle@medinformation.co.uk or telephone +44 808 304 2429 (Toll free-UK).

For stock control enquiries please email David Hammond: david.hammond@healthcarepharma.co.uk. Recipients of this Medicines Recall should bring.

Class 4 caution in use - Levetiracetam Accord 100mg/ml oral solution

Accord Healthcare Limited, UK has informed the MHRA that the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SPC) do not contain all the required safety information.
 
MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-notification-levetiracetam-accord-100mg-slash-ml-oral-solution-accord-healthcare-limited-uk-el-25-a-slash-40?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=9f75ebd8-3b27-4733-8087-29486e7f8a54&utm_content=immediately

MHRA drug alert date: 14/08/25

This is a caution in use only we are not accepting stock returns
 
For medical information enquiries please contact:

Accord Medical Information Department on 01271 385257, email- medinfo@accord-healthcare.com.

For stock control enquiries please contact: Accord- Customer Services Team on 0800 373573.

Class 2 recall-Fucidin 250mg tabs

LEO Pharma is recalling the affected batch as a precautionary measure due to out of specification results for impurities during routine stability testing.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-fucidin-250-mg-tablets-leo-laboratories-ltd-trading-as-leo-pharma-el-25-a-slash-38

MHRA drug alert date: 02/08/25

Further Information

For all enquiries and information on this product, please email medical-info.uk@leo-pharma.com or telephone 01844 347 333 and press 2 for Medical Information.

Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 Caution in use-Olmesartan medoxomil 10mg film-coated tablets, Jubilant Pharmaceuticals

Jubilant Pharmaceuticals NV has informed the MHRA that the Patient Information leaflet (PIL) in the cartons for the batches listed in this notification include an outdated PIL.

MHRA drug alert link:Class 4 Medicines Defect Notification: Olmesartan medoxomil 10mg film-coated tablets, Jubilant Pharmaceuticals NV, EL(25)A/37 - GOV.UK

MHRA drug alert date:31/07/25

This is a caution in use only we are not accepting stock returns

Further Information

For medical information enquiries please email safety.uk@lambda-cro.com, or telephone  0800 0668348.

For stock control enquiries please email JPUK.Customerservice@jubl.com, or telephone 01233 552293